TY - JOUR
T1 - Cardiovascular care of the oncology patient during COVID-19
T2 - An expert consensus document from the ACC cardio-oncology and imaging councils
AU - Baldassarre, Lauren A.
AU - Yang, Eric H.
AU - Cheng, Richard K.
AU - DeCara, Jeanne M.
AU - Dent, Susan
AU - Liu, Jennifer E.
AU - Rudski, Lawrence G.
AU - Strom, Jordan B.
AU - Thavendiranathan, Paaladinesh
AU - Barac, Ana
AU - Zaha, Vlad G.
AU - Bucciarelli-Ducci, Chiara
AU - Ellahham, Samer
AU - Deswal, Anita
AU - Lenneman, Carrie
AU - Villarraga, Hector R.
AU - Blaes, Anne H.
AU - Ismail-Khan, Roohi
AU - Ky, Bonnie
AU - Leja, Monika J.
AU - Scherrer-Crosbie, Marielle
N1 - Funding Information:
LAB: research support from American Heart Association (18CDA34110361). JBS: NIH/NHLBI K23 (1K23HL144907) grant funding from Edwards Lifesciences, consulting for Philips Healthcare, and speaker fees from Northwest Imaging Forums. PT: supported by the Canadian Institutes of Health Research New Investigator Award and Canada Research Chair in Cardiooncology. VGZ: research support from The Cancer Prevention Research Institute of Texas (RP180404). CBD: in part supported by the NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. MSC: 1R01HL130539 (NIH-NHLBI).
Publisher Copyright:
© The Author(s) 2020. Published by Oxford University Press. All rights reserved.
PY - 2021/5/1
Y1 - 2021/5/1
N2 - In response to the coronavirus disease 2019 (COVID-19) pandemic, the Cardio-Oncology and Imaging Councils of the American College of Cardiology offers recommendations to clinicians regarding the cardiovascular care of cardio-oncology patients in this expert consensus statement. Cardio-oncology patients-individuals with an active or prior cancer history and with or at risk of cardiovascular disease-are a rapidly growing population who are at increased risk of infection, and experiencing severe and/or lethal complications by COVID-19. Recommendations for optimizing screening and monitoring visits to detect cardiac dysfunction are discussed. In addition, judicious use of multimodality imaging and biomarkers are proposed to identify myocardial, valvular, vascular, and pericardial involvement in cancer patients. The difficulties of diagnosing the etiology of cardiovascular complications in patients with cancer and COVID-19 are outlined, along with weighing the advantages against risks of exposure, with the modification of existing cardiovascular treatments and cardiotoxicity surveillance in patients with cancer during the COVID-19 pandemic.
AB - In response to the coronavirus disease 2019 (COVID-19) pandemic, the Cardio-Oncology and Imaging Councils of the American College of Cardiology offers recommendations to clinicians regarding the cardiovascular care of cardio-oncology patients in this expert consensus statement. Cardio-oncology patients-individuals with an active or prior cancer history and with or at risk of cardiovascular disease-are a rapidly growing population who are at increased risk of infection, and experiencing severe and/or lethal complications by COVID-19. Recommendations for optimizing screening and monitoring visits to detect cardiac dysfunction are discussed. In addition, judicious use of multimodality imaging and biomarkers are proposed to identify myocardial, valvular, vascular, and pericardial involvement in cancer patients. The difficulties of diagnosing the etiology of cardiovascular complications in patients with cancer and COVID-19 are outlined, along with weighing the advantages against risks of exposure, with the modification of existing cardiovascular treatments and cardiotoxicity surveillance in patients with cancer during the COVID-19 pandemic.
UR - http://www.scopus.com/inward/record.url?scp=85106070041&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106070041&partnerID=8YFLogxK
U2 - 10.1093/jnci/djaa177
DO - 10.1093/jnci/djaa177
M3 - Review article
C2 - 33179744
AN - SCOPUS:85106070041
SN - 0027-8874
VL - 113
SP - 513
EP - 522
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 5
ER -